Marieke van de Ven

17PUBLICATIONS
169CO-AUTHORS
Molecular targetsAnimal cell and molecular biologyCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

|Dec 29, 2025
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg

|Dec 10, 2025
A quality framework for cryopreserved rodent disease models: INFRAFRONTIER quality principles in EMMA archiving and distribution.

Hilke Ehlich, Andrew Blease, Reva Biju

|Sep 30, 2025
Mechanisms of dexamethasone-induced bone toxicity in developing bone: a single-cell perspective.

Kelly Warmink, Philip Lijnzaad, Stephanie A Schubert

|Aug 13, 2025
NASP modulates histone turnover to drive PARP inhibitor resistance.

Sarah C Moser, Anna Khalizieva, Josef Roehsner

|Jun 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko

Pageof 3

Frequent Collaborators

11 joint publications

Jos Jonkers

4 joint publications

Lodewyk F A Wessels

4 joint publications

Jinhyuk Bhin

4 joint publications

Bjørn Siteur